E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese

Gynecologic Oncology

Volumn 108, Issue 2, 2008, Pages 409-414

  Li, Yan ^a   Liang, Jun ^a   Kang, Shan ^a   Dong, Zhiming ^a   Wang, Na ^a   Xing, Huimin ^a   Zhou, Rongmiao ^a   Li, Xiulan ^a   Zhao, Xiwa ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

E cadherin; Epithelium ovarian cancer; Expression; Single nucleotide polymorphism; Susceptibility

Indexed keywords

UVOMORULIN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CANCER RISK; CANCER TISSUE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

3' UNTRANSLATED REGIONS; ADULT; CADHERINS; CASE-CONTROL STUDIES; CHINA; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 38649107822     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.10.024     Document Type: Article

References (29)

1. Sundfeldt K., Piontkewitz Y., Ivarsson K., Nilsson O., Hellberg P., Brannstrom M., et al. E-cadherin expression in human epithelial ovarian cancer and normal ovary. Int J Cancer 74 (1997) 275-280
2. Shimoyama Y., Hirohashi S., Hirano S., Noguchi M., Shimosato Y., Takeichi M., et al. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res 49 (1989) 2128-2133
3. Frixen U.H., Behrens J., Sachs M., Eberle G., Voss B., Warda A., et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113 (1991) 173-185
4. Frixen U.H., Behrens J., Sachs M., Eberle G., Voss B., Warda A., et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113 (1991) 173-185
5. Birchmeier W., and Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 27 (1994) 11-26
6. Yoshida R., Kimura N., Harada Y., and Ohuchi N. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer. Int J Oncol 18 (2001) 513-520
7. Huiping C., Kristjansdottir S., Jonasson J.G., Magnusson J., Egilsson V., and Ingvarsson S. Alterations of E-cadherin and beta-catenin in gastric cancer. BMC Cancer 1 (2001) 16
8. Chan A.O. E-cadherin in gastric cancer. World J Gastroenterol 12 (2006) 199-203
9. Park W.S., Cho Y.G., Park J.K., Kim C.J., Kim H.S., Lee J.W., et al. A single nucleotide polymorphism in the E-cadherin gene promoter-160 is not associated with risk of Korean gastric cancer. J Korean Med Sci 18 (2003) 501-504
10. Liu Y.C., Shen C.Y., and Wu H.S. Mechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas. World J Gastroenterol 12 (2006) 2168-2173
11. Caldeira J.R., Prando E.C., Quevedo F.C., Neto F.A., Rainho C.A., Rogatto S.R., et al. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. BMC Cancer 2 (2006) 48
12. Li L.C., Chui R.M., Sasaki M., Nakajima K., Perinchery G., Au H.C., et al. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 60 (2002) 873-876
13. Nakamura A., Shimazaki T., Kaneko K., Shibata M., Matsumura T., Nagai M., et al. Characterization of DNA polymorphisms in the E-cadherin gene (CDH1) promoter region. Mutat Res 502 (2002) 19-24
14. Wu H.C., Lai M.T., Wu C.I., Chen H.Y., Wan L., Tsai F.J., et al. Chen WC, E-cadherin gene 3′-UTR C/T polymorphism is associated with prostate cancer. Urol Int 75 (2005) 350-335
15. Verhage B.A., Van Houwelingen K., Ruijter T.E., Kiemeney L.A., and Schalken J.A. Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer. Int J Cancer 100 (2002) 683-685
16. Shin Y., Kim L.J., Kang H.C., Park J.H., Park H.R., Park H.W., et al. The E-cadherin - 347G → GA promoter polymorphism and its effect on transcriptional regulation. Carcinogenesis 25 (2004) 895-899
17. Miller S.A., Dybes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16 (1988) 1215
18. Becker H.F., Reich U., Schott C., and Hofler H. Single superoxide nucleotide polymorphisms in the human E-cadherin gene. Hum Genet 96 (1995) 739-740
19. Keirsebilck A., Van Hoorde L., Gao Y., De Bruyne G., Bruyneel E., Vermassen P., et al. Mechanisms of downregulation of transfected E-cadherin cDNA during formation of invasive tumors in syngeneic mice. Invasion Metastasis 18 (1998) 44-56
20. Ulrich C.M., Bigler J., Velicer C.M., Greene E.A., Farin F.M., Potter J.D., et al. Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene. Cancer Epidemiol Biomarkers Prev 9 (2000) 1381-1385
21. Wang J., Pitarque M., and Ingelman-Sundberg M. 3′-UTR polymorphism in the human CYP2A6 gene affects mRNA stability and enzyme expression. Biochem Biophys Res Commun 10 (2006) 491-497
22. Giroldi L.A., Bringuier P.P., De Weijert M., Jansen C., Van Bokhoven A., Schalken J.A., et al. Role of E boxes in the repression of E-cadherin expression. Biochem Biophys Res Commun 241 (1997) 453-458
23. Behrens J., Lowrick O., Klein-hitpass L., and Birchmeier W. The E-cadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element. Proc Natl Acad Sci 88 (1991) 11495-11499
24. Verhage B.A., Van Houwelingen K., Ruijter T.E., Kiemeney L.A., and Schalken J.A. Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer. Int J Cancer 100 (2002) 683-685
25. Jonsson B.A., Adami H.O., Hagglund M., Bergh A., Goransson I., and Stattin P. - 160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer. Int J Cancer 109 (2004) 348-352
26. Tsukino H., Kuroda Y., Imai H., Nakao H., Qiu D., Komiya Y., et al. Lack of evidence for the association of E-cadherin gene polymorphism with increased risk or progression of prostate cancer. Urol Int 72 (2004) 203-207
27. Wu M.S., Huang S.P., Chang Y.T., Lin M.T., Shun C.T., Chang M.C., et al. Association of the - 160 C → A promoter polymorphism of E-cadherin gene with gastric carcinoma risk. Cancer 94 (2002) 1443-1448
28. Shin Y., Kim L.J., Kang H.C., Park J.H., Park H.R., Park H.W., et al. The E-cadherin - 347G → GA promoter polymorphism and its effect on transcriptional regulation. Carcinogenesis 25 (2004) 895-899
29. Shin Y., Kim I.J., Kang H.C., Park J.H., Park H.W., Jang S.G., et al. A functional polymorphism (- 347 G → GA) in the E-cadherin gene is associated with colorectal cancer. Carcinogenesis 25 (2004) 2173-2176